Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955666 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects
A Phase 1 study, sponsored by Provention Bio.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT03955666 is a Phase 1 study that has completed, run by Provention Bio. The registered enrollment target is 16 participants.
The verdict
NCT03955666, a Phase 1 study, has completed, sponsored by Provention Bio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This Phase 1b study will evaluate the safety of PRV-3279 in healthy adult subjects
Interventions
- BIOLOGICAL PRV-3279 or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-08-07 |
| Est. Completion | 2019-12-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03955666
The ClinicalTrials.gov registry entry for NCT03955666 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Provention Bio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRV-3279 or placebo is the first listed.
NCT03955666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03955666 about?
NCT03955666 is a clinical study titled "A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects". This Phase 1b study will evaluate the safety of PRV-3279 in healthy adult subjects
What is the current status of trial NCT03955666?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2019-08-07. Estimated completion is 2019-12-11.
What interventions are being tested in trial NCT03955666?
The interventions under investigation include: PRV-3279 or placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT03955666?
This trial is sponsored by Provention Bio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.